Literature DB >> 3719110

Bone-marrow plasmocytosis--an immunohistological study.

F Eckert, L Schmid, D Kradolfer, U Schmid.   

Abstract

Bone-marrow biopsies and smears from 59 patients with reactive plasmocytosis (22), multiple myeloma (24), solitary plasmocytoma (3) and monoclonal gammopathy of undetermined significance (MGUS) (10) were examined. To demonstrate cytoplasmic immunoglobulin the immunoperoxidase method was applied and evaluated quantitatively. Immunohistology yielded different ranges in kappa/lambda ratio for reactive plasmocytosis (0.4-3.5), multiple myeloma (less than or equal to 0.1 and greater than or equal to 11.2) and MGUS (0.2-3.0). As a result this method seems to be helpful in characterizing a plasmocytosis and distinguishing overt myeloma from monoclonal gammopathy of undetermined significance and reactive plasmocytosis. A differentiation of monoclonal gammopathy of undetermined significance from reactive plasmocytosis is not possible histologically and immunohistologically.

Entities:  

Mesh:

Year:  1986        PMID: 3719110     DOI: 10.1007/bf00320578

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  22 in total

1.  Multiple myeloma or benign monoclonal gammopathy? A study of differential diagnostic criteria in 44 cases.

Authors:  F D Lindström; U Dahlström
Journal:  Clin Immunol Immunopathol       Date:  1978-06

2.  The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique.

Authors:  B L Mepham; W Frater; B S Mitchell
Journal:  Histochem J       Date:  1979-05

3.  Use of bone marrow particle sections in the diagnosis of multiple myeloma.

Authors:  D D Canale; R D Collins
Journal:  Am J Clin Pathol       Date:  1974-03       Impact factor: 2.493

4.  Bone marrow biopsy with unaltered architecture: a new biopsy device.

Authors:  K Jamshidi; W R Swaim
Journal:  J Lab Clin Med       Date:  1971-02

5.  Clinical, morphological, and cell kinetic differences among multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma.

Authors:  P R Greipp; R A Kyle
Journal:  Blood       Date:  1983-07       Impact factor: 22.113

6.  The immunohistological detection of intracellular immunoglobulin in formalin-paraffin sections from multiple myeloma and related conditions using the immunoperoxidase technique.

Authors:  C R Taylor; D Y Mason
Journal:  Clin Exp Immunol       Date:  1974-11       Impact factor: 4.330

7.  Bone marrow percentage of plasma cells in the staging of monoclonal gammopathies.

Authors:  D Vercelli; R Di Guglielmo; G Guidi; L Scolari; L Buricchi; F Cozzolino
Journal:  Nouv Rev Fr Hematol       Date:  1980

8.  Cytoplasmic immunoglobulins in bone marrow cells of polyclonal and of monoclonal origin.

Authors:  A Morell; F Skvaril; H J Huser; G Spengler; S Barandun
Journal:  Acta Haematol       Date:  1978       Impact factor: 2.195

9.  Specific identification of intracellular immunoglobulin in paraffin sections of multiple myeloma and macroglobulinemia using an immunoperoxidase technique.

Authors:  G S Pinkus; J W Said
Journal:  Am J Pathol       Date:  1977-04       Impact factor: 4.307

10.  Immunoperoxidase staining of bone marrow sections.

Authors:  J L Hitzman; C Y Li; R A Kyle
Journal:  Cancer       Date:  1981-12-01       Impact factor: 6.860

View more
  3 in total

Review 1.  Bone marrow immunohistology of plasma cell neoplasms.

Authors:  A Wei; S Juneja
Journal:  J Clin Pathol       Date:  2003-06       Impact factor: 3.411

2.  Differentiation of plasma cell infiltrates in the bone marrow. A clinicopathological study on 80 patients including immunohistochemistry and morphometry.

Authors:  J Thiele; B Arenz; H Klein; M Vierbuchen; R Zankovich; R Fischer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

3.  An approach for diagnosing plasma cell myeloma by three-color flow cytometry based on kappa/lambda ratios of CD38-gated CD138(+) cells.

Authors:  Shoko Nakayama; Taiji Yokote; Yuji Hirata; Kazuki Iwaki; Toshikazu Akioka; Takuji Miyoshi; Ayami Takayama; Uta Nishiwaki; Yuki Masuda; Toshiyuki Ikemoto; Hidema Tanaka; Yasuichiro Nishimura; Motomu Tsuji; Toshiaki Hanafusa
Journal:  Diagn Pathol       Date:  2012-09-28       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.